Report Detail

Other Global Gastrointestinal Therapeutics Market Size, Status and Forecast 2019-2025

  • RnM3411291
  • |
  • 10 July, 2020
  • |
  • Global
  • |
  • 127 Pages
  • |
  • QYResearch
  • |
  • Other

Gastrointestinal Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gastrointestinal Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
AbbVie
Allergan
Johnson & Johnson
Takeda
Novartis
Pfizer
Merck
F. Hoffmann-La Roche
Eli Lilly
AstraZeneca
Procter & Gamble
Tillotts Pharma
Takeda
GlaxoSmithKline
Amgen

Market segment by Type, the product can be split into
Oral
Parenteral
Market segment by Application, split into
IBD
Irritable Bowel Syndrome (IBS)

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Gastrointestinal Therapeutics Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Gastrointestinal Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Oral
    • 1.4.3 Parenteral
  • 1.5 Market by Application
    • 1.5.1 Global Gastrointestinal Therapeutics Market Share by Application: 2020 VS 2026
    • 1.5.2 IBD
    • 1.5.3 Irritable Bowel Syndrome (IBS)
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Gastrointestinal Therapeutics Market Perspective (2015-2026)
  • 2.2 Global Gastrointestinal Therapeutics Growth Trends by Regions
    • 2.2.1 Gastrointestinal Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Gastrointestinal Therapeutics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Gastrointestinal Therapeutics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Gastrointestinal Therapeutics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Gastrointestinal Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Gastrointestinal Therapeutics Players by Market Size
    • 3.1.1 Global Top Gastrointestinal Therapeutics Players by Revenue (2015-2020)
    • 3.1.2 Global Gastrointestinal Therapeutics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Gastrointestinal Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Gastrointestinal Therapeutics Market Concentration Ratio
    • 3.2.1 Global Gastrointestinal Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Gastrointestinal Therapeutics Revenue in 2019
  • 3.3 Gastrointestinal Therapeutics Key Players Head office and Area Served
  • 3.4 Key Players Gastrointestinal Therapeutics Product Solution and Service
  • 3.5 Date of Enter into Gastrointestinal Therapeutics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Gastrointestinal Therapeutics Historic Market Size by Type (2015-2020)
  • 4.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Gastrointestinal Therapeutics Market Size by Application (2015-2020)
  • 5.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Gastrointestinal Therapeutics Market Size (2015-2020)
  • 6.2 Gastrointestinal Therapeutics Key Players in North America (2019-2020)
  • 6.3 North America Gastrointestinal Therapeutics Market Size by Type (2015-2020)
  • 6.4 North America Gastrointestinal Therapeutics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Gastrointestinal Therapeutics Market Size (2015-2020)
  • 7.2 Gastrointestinal Therapeutics Key Players in Europe (2019-2020)
  • 7.3 Europe Gastrointestinal Therapeutics Market Size by Type (2015-2020)
  • 7.4 Europe Gastrointestinal Therapeutics Market Size by Application (2015-2020)

8 China

  • 8.1 China Gastrointestinal Therapeutics Market Size (2015-2020)
  • 8.2 Gastrointestinal Therapeutics Key Players in China (2019-2020)
  • 8.3 China Gastrointestinal Therapeutics Market Size by Type (2015-2020)
  • 8.4 China Gastrointestinal Therapeutics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Gastrointestinal Therapeutics Market Size (2015-2020)
  • 9.2 Gastrointestinal Therapeutics Key Players in Japan (2019-2020)
  • 9.3 Japan Gastrointestinal Therapeutics Market Size by Type (2015-2020)
  • 9.4 Japan Gastrointestinal Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Gastrointestinal Therapeutics Market Size (2015-2020)
  • 10.2 Gastrointestinal Therapeutics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Gastrointestinal Therapeutics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Gastrointestinal Therapeutics Market Size by Application (2015-2020)

11 India

  • 11.1 India Gastrointestinal Therapeutics Market Size (2015-2020)
  • 11.2 Gastrointestinal Therapeutics Key Players in India (2019-2020)
  • 11.3 India Gastrointestinal Therapeutics Market Size by Type (2015-2020)
  • 11.4 India Gastrointestinal Therapeutics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Gastrointestinal Therapeutics Market Size (2015-2020)
  • 12.2 Gastrointestinal Therapeutics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Gastrointestinal Therapeutics Market Size by Type (2015-2020)
  • 12.4 Central & South America Gastrointestinal Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 AbbVie
    • 13.1.1 AbbVie Company Details
    • 13.1.2 AbbVie Business Overview
    • 13.1.3 AbbVie Gastrointestinal Therapeutics Introduction
    • 13.1.4 AbbVie Revenue in Gastrointestinal Therapeutics Business (2015-2020))
    • 13.1.5 AbbVie Recent Development
  • 13.2 Allergan
    • 13.2.1 Allergan Company Details
    • 13.2.2 Allergan Business Overview
    • 13.2.3 Allergan Gastrointestinal Therapeutics Introduction
    • 13.2.4 Allergan Revenue in Gastrointestinal Therapeutics Business (2015-2020)
    • 13.2.5 Allergan Recent Development
  • 13.3 Johnson & Johnson
    • 13.3.1 Johnson & Johnson Company Details
    • 13.3.2 Johnson & Johnson Business Overview
    • 13.3.3 Johnson & Johnson Gastrointestinal Therapeutics Introduction
    • 13.3.4 Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2015-2020)
    • 13.3.5 Johnson & Johnson Recent Development
  • 13.4 Takeda
    • 13.4.1 Takeda Company Details
    • 13.4.2 Takeda Business Overview
    • 13.4.3 Takeda Gastrointestinal Therapeutics Introduction
    • 13.4.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2015-2020)
    • 13.4.5 Takeda Recent Development
  • 13.5 Novartis
    • 13.5.1 Novartis Company Details
    • 13.5.2 Novartis Business Overview
    • 13.5.3 Novartis Gastrointestinal Therapeutics Introduction
    • 13.5.4 Novartis Revenue in Gastrointestinal Therapeutics Business (2015-2020)
    • 13.5.5 Novartis Recent Development
  • 13.6 Pfizer
    • 13.6.1 Pfizer Company Details
    • 13.6.2 Pfizer Business Overview
    • 13.6.3 Pfizer Gastrointestinal Therapeutics Introduction
    • 13.6.4 Pfizer Revenue in Gastrointestinal Therapeutics Business (2015-2020)
    • 13.6.5 Pfizer Recent Development
  • 13.7 Merck
    • 13.7.1 Merck Company Details
    • 13.7.2 Merck Business Overview
    • 13.7.3 Merck Gastrointestinal Therapeutics Introduction
    • 13.7.4 Merck Revenue in Gastrointestinal Therapeutics Business (2015-2020)
    • 13.7.5 Merck Recent Development
  • 13.8 F. Hoffmann-La Roche
    • 13.8.1 F. Hoffmann-La Roche Company Details
    • 13.8.2 F. Hoffmann-La Roche Business Overview
    • 13.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Introduction
    • 13.8.4 F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2015-2020)
    • 13.8.5 F. Hoffmann-La Roche Recent Development
  • 13.9 Eli Lilly
    • 13.9.1 Eli Lilly Company Details
    • 13.9.2 Eli Lilly Business Overview
    • 13.9.3 Eli Lilly Gastrointestinal Therapeutics Introduction
    • 13.9.4 Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2015-2020)
    • 13.9.5 Eli Lilly Recent Development
  • 13.10 AstraZeneca
    • 13.10.1 AstraZeneca Company Details
    • 13.10.2 AstraZeneca Business Overview
    • 13.10.3 AstraZeneca Gastrointestinal Therapeutics Introduction
    • 13.10.4 AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2015-2020)
    • 13.10.5 AstraZeneca Recent Development
  • 13.11 Procter & Gamble
    • 10.11.1 Procter & Gamble Company Details
    • 10.11.2 Procter & Gamble Business Overview
    • 10.11.3 Procter & Gamble Gastrointestinal Therapeutics Introduction
    • 10.11.4 Procter & Gamble Revenue in Gastrointestinal Therapeutics Business (2015-2020)
    • 10.11.5 Procter & Gamble Recent Development
  • 13.12 Tillotts Pharma
    • 10.12.1 Tillotts Pharma Company Details
    • 10.12.2 Tillotts Pharma Business Overview
    • 10.12.3 Tillotts Pharma Gastrointestinal Therapeutics Introduction
    • 10.12.4 Tillotts Pharma Revenue in Gastrointestinal Therapeutics Business (2015-2020)
    • 10.12.5 Tillotts Pharma Recent Development
  • 13.13 Takeda
    • 10.13.1 Takeda Company Details
    • 10.13.2 Takeda Business Overview
    • 10.13.3 Takeda Gastrointestinal Therapeutics Introduction
    • 10.13.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2015-2020)
    • 10.13.5 Takeda Recent Development
  • 13.14 GlaxoSmithKline
    • 10.14.1 GlaxoSmithKline Company Details
    • 10.14.2 GlaxoSmithKline Business Overview
    • 10.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Introduction
    • 10.14.4 GlaxoSmithKline Revenue in Gastrointestinal Therapeutics Business (2015-2020)
    • 10.14.5 GlaxoSmithKline Recent Development
  • 13.15 Amgen
    • 10.15.1 Amgen Company Details
    • 10.15.2 Amgen Business Overview
    • 10.15.3 Amgen Gastrointestinal Therapeutics Introduction
    • 10.15.4 Amgen Revenue in Gastrointestinal Therapeutics Business (2015-2020)
    • 10.15.5 Amgen Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Summary:
    Get latest Market Research Reports on Gastrointestinal Therapeutics. Industry analysis & Market Report on Gastrointestinal Therapeutics is a syndicated market report, published as Global Gastrointestinal Therapeutics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Gastrointestinal Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,088.80
    4,633.20
    6,177.60
    3,611.40
    5,417.10
    7,222.80
    590,265.00
    885,397.50
    1,180,530.00
    325,260.00
    487,890.00
    650,520.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report